These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat. Hilakivi I; Rinne J; Marjamäki P Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962 [TBL] [Abstract][Full Text] [Related]
28. Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptors. Schoffelmeer AN; Hogenboom F; Mulder AH; Ronken E; Stoof JC; Drukarch B Synapse; 1994 Jul; 17(3):190-5. PubMed ID: 7974202 [TBL] [Abstract][Full Text] [Related]
29. Pharmacological characteristics of hyperambulation induced by the sigma ligand (+)-3-PPP in rats. Hirotsu I; Koyama M; Honbo N; Ohno T Jpn J Pharmacol; 1994 May; 65(1):1-7. PubMed ID: 7916383 [TBL] [Abstract][Full Text] [Related]
30. [125I](S)-trans-7-OH-PIPAT: a potential spect imaging agent for sigma binding sites. Garner SE; Kung MP; Foulon C; Chumpradit S; Kung HF Life Sci; 1994; 54(9):593-603. PubMed ID: 8114613 [TBL] [Abstract][Full Text] [Related]
31. Effects of sigma receptor ligands on the extracellular concentration of dopamine in the striatum and prefrontal cortex of the rat. Gudelsky GA Eur J Pharmacol; 1995 Nov; 286(3):223-8. PubMed ID: 8608783 [TBL] [Abstract][Full Text] [Related]
33. Sigma binding sites identified by [(3)H] DTG are elevated in aged Fischer-344 x Brown Norway (F1) rats. Wallace DR; Mactutus CF; Booze RM Synapse; 2000 Mar; 35(4):311-3. PubMed ID: 10657041 [No Abstract] [Full Text] [Related]
34. Signalling via rat dopamine D2-receptors expressed in mouse fibroblasts is not influenced by compounds binding to the sigma sites of these cells. Sommermeyer H; Dompert WU; Glaser T Cell Signal; 1993 Nov; 5(6):747-52. PubMed ID: 8130078 [TBL] [Abstract][Full Text] [Related]
35. Identification of regions of the sigma-1 receptor ligand binding site using a novel photoprobe. Pal A; Hajipour AR; Fontanilla D; Ramachandran S; Chu UB; Mavlyutov T; Ruoho AE Mol Pharmacol; 2007 Oct; 72(4):921-33. PubMed ID: 17622576 [TBL] [Abstract][Full Text] [Related]
36. Allosteric modulation of peripheral sigma binding sites by a new selective ligand: SR 31747. Paul R; Lavastre S; Floutard D; Floutard R; Canat X; Casellas P; Le Fur G; Brelière JC J Neuroimmunol; 1994 Jul; 52(2):183-92. PubMed ID: 7794416 [TBL] [Abstract][Full Text] [Related]
37. Decrease in sigma but no increase in striatal dopamine D4 sites in schizophrenic brains. Helmeste DM; Tang SW; Bunney WE; Potkin SG; Jones EG Eur J Pharmacol; 1996 Oct; 314(3):R3-5. PubMed ID: 8957266 [TBL] [Abstract][Full Text] [Related]
38. Benz[f]isoquinoline analogues as high-affinity sigma ligands. Russell MG; Baker R; Billington DC; Knight AK; Middlemiss DN; Noble AJ J Med Chem; 1992 May; 35(11):2025-33. PubMed ID: 1317922 [TBL] [Abstract][Full Text] [Related]
39. Pharmacological characterization of sigma binding sites in guinea pig brain membranes. Karbon EW; Enna SJ Adv Exp Med Biol; 1991; 287():51-9. PubMed ID: 1662016 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and pharmacological evaluation of potent and enantioselective sigma 1, and sigma 2 ligands. Marrazzo A; Prezzavento O; Pasquinucci L; Vittorio F; Ronsisvalle G Farmaco; 2001 Mar; 56(3):181-9. PubMed ID: 11409325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]